V. Ozmen Et Al. , "The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial," 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , Barcelona, Spain, 2019
Ozmen, V. Et Al. 2019. The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial. 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , (Barcelona, Spain).
Ozmen, V., Ozbas, S., Karanlik, H., Muslumanoglu, M., Igci, A., Canturk, Z., ... Utkan, Z.(2019). The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial . 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain
Ozmen, V. Et Al. "The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial," 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 2019
Ozmen, V. Et Al. "The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial." 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , Barcelona, Spain, 2019
Ozmen, V. Et Al. (2019) . "The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial." 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , Barcelona, Spain.
@conferencepaper{conferencepaper, author={V. Ozmen Et Al. }, title={The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial}, congress name={44th Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Barcelona}, country={Spain}, year={2019}}